These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 6538355)
21. 9,11-Iminoepoxyprosta-5,13-dienoic acid is a selective thromboxane A2 synthetase inhibitor. Fitzpatrick F; Gorman R; Bundy G; Honohan T; McGuire J; Sun F Biochim Biophys Acta; 1979 May; 573(2):238-44. PubMed ID: 375987 [TBL] [Abstract][Full Text] [Related]
22. Combination of inhibition of thrombin and blockade of thromboxane A2 synthetase and receptors enhances thrombolysis and delays reocclusion in canine coronary arteries. Yao SK; Ober JC; Ferguson JJ; Anderson HV; Maraganore J; Buja LM; Willerson JT Circulation; 1992 Dec; 86(6):1993-9. PubMed ID: 1451271 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation. Nicolaou KC; Magolda RL; Smith JB; Aharony D; Smith EF; Lefer AM Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2566-70. PubMed ID: 288046 [TBL] [Abstract][Full Text] [Related]
24. [Experimental study on the prevention of vasospasm following subarachnoid hemorrhage by a thromboxane A2 synthetase inhibitor, OKY-046]. Ohsugi S Nihon Geka Hokan; 1986 Mar; 55(2):297-305. PubMed ID: 3827476 [No Abstract] [Full Text] [Related]
25. Effects of ML-9 on experimental delayed cerebral vasospasm. Kokubu K; Tani E; Nakano M; Minami N; Shindo H J Neurosurg; 1989 Dec; 71(6):916-22. PubMed ID: 2585084 [TBL] [Abstract][Full Text] [Related]
26. The effects of RO-22-4679, a thromboxane synthetase inhibitor, on ventricular fibrillation induced by coronary artery occlusion in conscious dogs. Huddleston CB; Lupinetti FM; Laws KH; Collins JC; Clanton JA; Hawiger JJ; Oates JA; Hammon JW Circ Res; 1983 May; 52(5):608-13. PubMed ID: 6682723 [No Abstract] [Full Text] [Related]
27. The role of the prostacyclin-thromboxane system in cerebral vasospasm following induced subarachnoid hemorrhage in the rabbit. Chan RC; Durity FA; Thompson GB; Nugent RA; Kendall M J Neurosurg; 1984 Dec; 61(6):1120-8. PubMed ID: 6389786 [TBL] [Abstract][Full Text] [Related]
28. In vivo inhibition of thromboxane synthetase in infarcted canine myocardium. McCluskey ER; Kramer JB; Corr PB; Needleman P Biochem Biophys Res Commun; 1984 Jun; 121(2):552-7. PubMed ID: 6539597 [TBL] [Abstract][Full Text] [Related]
31. Effects of chlorpromazine on experimental delayed cerebral vasospasm. Nakano M; Tani E; Fukumori T; Yokota M J Neurosurg; 1984 Nov; 61(5):857-63. PubMed ID: 6491731 [TBL] [Abstract][Full Text] [Related]
32. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity. Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195 [TBL] [Abstract][Full Text] [Related]
33. Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury. Simpson PJ; Smith CB; Rosenthal G; Lucchesi BR J Pharmacol Exp Ther; 1986 Aug; 238(2):497-501. PubMed ID: 3735129 [TBL] [Abstract][Full Text] [Related]
34. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors. Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501 [TBL] [Abstract][Full Text] [Related]
35. [Research and development of ozagrel, a highly selective inhibitor of TXA2 synthase]. Nakazawa M; Iizuka K; Ujiie A; Hiraku S; Ohki S Yakugaku Zasshi; 1994 Dec; 114(12):911-33. PubMed ID: 7869235 [TBL] [Abstract][Full Text] [Related]
36. In vitro antiplatelet profiles of the new thromboxane synthetase inhibitor sodium 2-(1-imidazolylmethyl)-4,5-dihydrobenzo[b]thiophene-6-carboxylate. Asai F; Ito T; Ushiyama S; Matsuda K; Oshima T Arzneimittelforschung; 1991 May; 41(5):506-10. PubMed ID: 1898421 [TBL] [Abstract][Full Text] [Related]
37. Roles of endogenous prostacyclin and thromboxane A2 in the ischemic canine heart. Sakai K; Ito K; Ogawa K J Cardiovasc Pharmacol; 1982; 4(1):129-35. PubMed ID: 6176788 [TBL] [Abstract][Full Text] [Related]
38. Lack of protective effect of thromboxane synthetase inhibitor (CGS-13080) on single dose radiated canine intestine. Barter JF; Marlow D; Kamath RK; Harbert J; Torrisi JR; Barnes WA; Potkul RK; Newsome JT; Delgado G Gynecol Oncol; 1991 Mar; 40(3):218-21. PubMed ID: 2013442 [TBL] [Abstract][Full Text] [Related]
39. Post-treatment of transient focal cerebral ischemia in rats with the novel cerebrovascular-selective Ca2+ channel antagonist (+/-)-(E)-1-(3-fluoro-6,11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-pheny l-2-propenyl)-piperazine dimaleate. Minato H; Kikuta C; Masuda Y; Fujitani B; Hosoki K Arzneimittelforschung; 1997 Jul; 47(7):799-802. PubMed ID: 9272234 [TBL] [Abstract][Full Text] [Related]
40. Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity. Schumacher WA; Lucchesi BR J Pharmacol Exp Ther; 1983 Dec; 227(3):790-6. PubMed ID: 6418881 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]